Welcome to our dedicated page for Privia Health Group SEC filings (Ticker: PRVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Privia Health Group, Inc. (Nasdaq: PRVA) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Privia Health is a Delaware-incorporated, technology-driven physician enablement company based in Arlington, Virginia, and its filings offer detailed information about its financial condition, operations, governance, and material events.
Among the most frequently referenced documents are current reports on Form 8-K, which Privia Health uses to announce quarterly financial results, guidance updates, and other significant developments. For example, the company has filed 8-Ks to furnish press releases covering its first, second, and third quarter results, including metrics such as total revenue, net income, Adjusted EBITDA, Implemented Providers, Value-Based Care Attributed Lives, Practice Collections, Care Margin, and Platform Contribution. It has also filed 8-Ks to describe material events like the definitive agreement to acquire an Accountable Care Organization business from Evolent Health, Inc., and changes in its Board of Directors.
Investors analyzing PRVA can use annual reports on Form 10-K and quarterly reports on Form 10-Q (when available through EDGAR) to review segment information, risk factors, non-GAAP reconciliations, and detailed discussions of the company’s value-based care model and physician enablement platform. These filings also elaborate on regulatory risks, relationships with medical groups and providers, and dependencies on key technology vendors.
On Stock Titan, Privia Health filings are complemented by AI-powered summaries that explain the key points of lengthy documents such as 10-Ks and 10-Qs, and highlight notable items in 8-Ks. Users can quickly see what changed from prior periods, how management describes performance in value-based care programs like the Medicare Shared Savings Program, and where guidance or risk disclosures have been updated. The platform also surfaces relevant insider and governance-related filings, helping readers track board appointments, compensation plans, and other corporate actions disclosed to the SEC.
Privia Health Group, Inc. (PRVA) reported the passing of Board member Patricia Maryland on October 24, 2025. She served on the Board for five years and was Chair of the Compliance Committee. The company expressed gratitude for her service and contributions.
The report is filed under Item 8.01 (Other Events) and was signed by Chief Executive Officer Parth Mehrotra. No additional board or committee actions are described in this disclosure.
Privia Health Group, Inc. (PRVA) filed a Current Report describing material risks and uncertainties affecting its business. The filing highlights regulatory and compliance exposure in a heavily regulated healthcare environment, the complexity of relationships with medical groups and Privia providers, and execution risks for its growth strategy and proprietary cloud-based technology rollout. It notes reliance on key vendors such as athenahealth, Inc., potential reimbursement rate pressure from government and private payers, cybersecurity and privacy risks related to protected health information, and workforce availability and cost pressures. The report references risk disclosures through year ended December 31, 2024 and states information is current as of the report date.
Privia Health Group, Inc. Schedule 13G discloses that a Rubicon-linked group holds a material passive stake in the company's common stock. The Reporting Persons beneficially own 6,278,522 shares, representing 5.14% of the outstanding class based on the issuer's reported total of 122,673,254 shares. All voting and dispositive power over these shares is reported as shared (no sole voting or dispositive power). The shares are held through Puma Growth Holdings, LLC, with a clear chain of control: Puma owns the shares, RF OP GP acts as manager, RF OP GP 2 is the general partner of RF OP GP, and Rubicon Founders is the ultimate member; Adam Boehler is identified among the Reporting Persons. The filing is submitted on Schedule 13G and includes a certification that the stake is not held to influence control of the issuer.
Privia Health Group (PRVA) posted solid top-line growth in Q2 2025. Revenue rose 23.4 % to $521.2 million, driven by stronger Value-Based Care (capitated +34 % to $75.5 million; shared-savings +51 % to $60.0 million) and fee-for-service patient care of $331.5 million. Six-month revenue reached $1.00 billion, up 19.5 % year-over-year. Gross profit improved 14.8 % to $112.8 million.
Earnings moderated. Operating income fell to $3.3 million (-34.6 %), and net income attributable to PRVA slipped to $2.7 million (EPS basic $0.02 vs. $0.03). YTD net income rose 7.1 % to $6.9 million on better first-quarter results.
Cash deployment and balance sheet. The company closed a 51 % acquisition of Privia Medical Group Arizona for $89.1 million cash, lifting goodwill to $172.2 million and intangibles to $170.1 million. Cash & equivalents declined to $390.1 million from $491.1 million at year-end, reflecting the deal and a $16.1 million operating cash outflow. No borrowings are outstanding on the $125 million revolver; total debt remains zero. Stockholders’ equity increased to $733.5 million on share issuance and retained earnings.
Key operating metrics. Implemented providers grew 13.8 % to 5,125, and attributed lives rose 15.2 % to 1.38 million. Practice collections reached $862.9 million (+18.5 %). Provider liability climbed to $458.1 million, and accounts receivable to $444.0 million.
Management continues to highlight expansion into 16 markets, including recent entries into Indiana and Arizona, and underscores the shift toward higher-margin VBC contracts while maintaining a strong liquidity position.